2.095
price down icon2.56%   -0.0551
after-market Dopo l'orario di chiusura: 2.22 0.125 +5.97%
loading
Precedente Chiudi:
$2.1501
Aprire:
$2.4
Volume 24 ore:
6,516
Relative Volume:
0.65
Capitalizzazione di mercato:
$25.31M
Reddito:
$10.96M
Utile/perdita netta:
$-7.02M
Rapporto P/E:
-3.2734
EPS:
-0.64
Flusso di cassa netto:
$-3.72M
1 W Prestazione:
-5.20%
1M Prestazione:
-14.84%
6M Prestazione:
-43.74%
1 anno Prestazione:
-64.79%
Intervallo 1D:
Value
$2.095
$2.40
Intervallo di 1 settimana:
Value
$2.095
$2.53
Portata 52W:
Value
$2.00
$6.75

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
Nome
Collplant Biotechnologies Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
57
Name
Cinguettio
@CollplantBio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
CLGN's Discussions on Twitter

Confronta CLGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLGN
Collplant Biotechnologies Ltd
2.095 25.31M 10.96M -7.02M -3.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.19 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.58 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
656.65 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
273.55 32.98B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
254.16 26.92B 3.81B -644.79M -669.77M -6.24

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-02-17 Iniziato Alliance Global Partners Buy

Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie

pulisher
Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges - Investing.com India

Apr 23, 2025
pulisher
Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - simplywall.st

Mar 28, 2025
pulisher
Mar 28, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - Yahoo

Mar 28, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow

Mar 26, 2025
pulisher
Mar 26, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings - GuruFocus

Mar 25, 2025
pulisher
Mar 24, 2025

Collplant Biotechnologies Ltd expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday - Defense World

Mar 24, 2025
pulisher
Mar 19, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Quantisnow

Mar 19, 2025
pulisher
Mar 18, 2025

Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 18, 2025
pulisher
Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges - Investing.com India

Mar 05, 2025
pulisher
Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Israel-based CollPlant expands distribution for VergenixSTR in Europe and Asia - BSA bureau

Feb 25, 2025
pulisher
Feb 24, 2025

CollPlant expands VergenixSTR distribution in Europe and Asia By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant expands European and Asian distribution of soft tissue repair matrix - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant Expands Vergenix STR Distribution Across Europe And Asia - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Medical Breakthrough: CollPlant's Tendon Treatment Enters 4 New MarketsWhy It Matters - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia - PR Newswire

Feb 24, 2025
pulisher
Feb 12, 2025

CollPlant secures U.S. patent for dermal filler - Investing.com India

Feb 12, 2025
pulisher
Feb 12, 2025

CollPlant secures U.S. patent for dermal filler By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

CollPlant Biotechnologies Provides a Corporate Update - PR Newswire

Feb 12, 2025
pulisher
Feb 10, 2025

Tissue Engineering Market: Key Player Profiles, Industry US$ - openPR

Feb 10, 2025
pulisher
Feb 06, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Earns Buy Rating from D. Boral Capital - Defense World

Feb 06, 2025
pulisher
Jan 20, 2025

Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World

Jan 20, 2025

Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):